Literature DB >> 10970390

Characterization of Actinomyces isolates from infected root canals of teeth: description of Actinomyces radicidentis sp. nov.

M D Collins1, L Hoyles, S Kalfas, G Sundquist, T Monsen, N Nikolaitchouk, E Falsen.   

Abstract

Two strains of a previously undescribed Actinomyces-like bacterium were recovered in pure culture from infected root canals of teeth. Analysis by biochemical testing and polyacrylamide gel electrophoresis of whole-cell proteins indicated that the strains closely resembled each other phenotypically but were distinct from previously described Actinomyces and Arcanobacterium species. Comparative 16S rRNA gene-sequencing studies showed the bacterium to be a hitherto unknown subline within a group of Actinomyces species which includes Actinomyces bovis, the type species of the genus. Based on phylogenetic and phenotypic evidence, we propose that the unknown bacterium isolated from human clinical specimens be classified as Actinomyces radicidentis sp. nov. The type strain of Actinomyces radicidentis is CCUG 36733.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970390      PMCID: PMC87393     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysis-mass spectrometry and conventional biochemical tests.

Authors:  V Hall; G L O'Neill; J T Magee; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov.

Authors:  P A Lawson; E Falsen; E Akervall; P Vandamme; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1997-07

3.  Actinomyces europaeus sp. nov., isolated from human clinical specimens.

Authors:  G Funke; N Alvarez; C Pascual; E Falsen; E Akervall; L Sabbe; L Schouls; N Weiss; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1997-07

4.  Actinomyces graevenitzii sp. nov., isolated from human clinical specimens.

Authors:  C P Ramos; E Falsen; N Alvarez; E Akervall; B Sjödén; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1997-07

Review 5.  Polyphasic taxonomy, a consensus approach to bacterial systematics.

Authors:  P Vandamme; B Pot; M Gillis; P de Vos; K Kersters; J Swings
Journal:  Microbiol Rev       Date:  1996-06

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  Description of human-derived Centers for Disease Control coryneform group 2 bacteria as Actinomyces bernardiae sp. nov.

Authors:  G Funke; C P Ramos; J F Fernández-Garayzábal; N Weiss; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1995-01

8.  Assignment of human-derived CDC group 1 coryneform bacteria and CDC group 1-like coryneform bacteria to the genus Actinomyces as Actinomyces neuii subsp. neuii sp. nov., subsp. nov., and Actinomyces neuii subsp. anitratus subsp. nov.

Authors:  G Funke; S Stubbs; A von Graevenitz; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1994-01

9.  Assignment of Actinomyces pyogenes-like (CDC coryneform group E) bacteria to the genus Actinomyces as Actinomyces radingae sp. nov. and Actinomyces turicensis sp. nov.

Authors:  J Wüst; S Stubbs; N Weiss; G Funke; M D Collins
Journal:  Lett Appl Microbiol       Date:  1995-02       Impact factor: 2.858

  9 in total
  14 in total

1.  Phenotypic identification of Actinomyces and related species isolated from human sources.

Authors:  N Sarkonen; E Könönen; P Summanen; M Könönen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Identification of clinical isolates of actinomyces species by amplified 16S ribosomal DNA restriction analysis.

Authors:  V Hall; P R Talbot; S L Stubbs; B I Duerden
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Authors:  Anne-Marie Santala; Nanna Sarkonen; Val Hall; Petteri Carlson; Hannele Jousimies-Somer; Eija Könönen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

4.  Characterization of some actinomyces-like isolates from human clinical sources: description of Varibaculum cambriensis gen nov, sp nov.

Authors:  Val Hall; Matthew D Collins; Paul A Lawson; Roger A Hutson; Enevold Falsen; Elisabeth Inganas; Brian Duerden
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

5.  Genome-Based Taxonomic Classification of the Phylum Actinobacteria.

Authors:  Imen Nouioui; Lorena Carro; Marina García-López; Jan P Meier-Kolthoff; Tanja Woyke; Nikos C Kyrpides; Rüdiger Pukall; Hans-Peter Klenk; Michael Goodfellow; Markus Göker
Journal:  Front Microbiol       Date:  2018-08-22       Impact factor: 5.640

Review 6.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Actinomyces cardiffensis sp. nov. from human clinical sources.

Authors:  Val Hall; Mattew D Collins; Roger Hutson; Enevold Falsen; Brian I Duerden
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Genotypic diversity of clinical Actinomyces species: phenotype, source, and disease correlation among genospecies.

Authors:  Jill E Clarridge; Qing Zhang
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Role of hydrogen peroxide in competition and cooperation between Streptococcus gordonii and Actinomyces naeslundii.

Authors:  Nicholas S Jakubovics; Steven R Gill; M Margaret Vickerman; Paul E Kolenbrander
Journal:  FEMS Microbiol Ecol       Date:  2008-09-09       Impact factor: 4.194

10.  Salivary statherin peptide-binding epitopes of commensal and potentially infectious Actinomyces spp. delineated by a hybrid peptide construct.

Authors:  Liza Danielsson Niemi; Ingegerd Johansson
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.